| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activation of toll-like receptor signaling pathway for protection against influenza virus infection
|
Wong, J.P.
|
|
2009
|
27 |
25-26 |
p. 3481-3483
3 p.
|
article
|
| 2 |
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: The importance of cross-protection
|
Ansaldi, Filippo
|
|
2009
|
27 |
25-26 |
p. 3345-3348
4 p.
|
article
|
| 3 |
Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens
|
Courtney, Amy N.
|
|
2009
|
27 |
25-26 |
p. 3335-3341
7 p.
|
article
|
| 4 |
Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
|
Jasani, B.
|
|
2009
|
27 |
25-26 |
p. 3401-3404
4 p.
|
article
|
| 5 |
An E7-based therapeutic vaccine protects mice against HPV16 associated cancer
|
Venuti, Aldo
|
|
2009
|
27 |
25-26 |
p. 3395-3397
3 p.
|
article
|
| 6 |
A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plague
|
Chichester, Jessica A.
|
|
2009
|
27 |
25-26 |
p. 3471-3474
4 p.
|
article
|
| 7 |
Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy)
|
Panatto, D.
|
|
2009
|
27 |
25-26 |
p. 3450-3453
4 p.
|
article
|
| 8 |
Changes in the evolution of meningococcal disease, 2001–2008, Catalonia (Spain)
|
Martínez, Ana I.
|
|
2009
|
27 |
25-26 |
p. 3496-3498
3 p.
|
article
|
| 9 |
Composition of the ANTIGENome of Helicobacter pylori defined by human serum antibodies
|
Meinke, Andreas
|
|
2009
|
27 |
25-26 |
p. 3251-3259
9 p.
|
article
|
| 10 |
Detection of LP2086 on the cell surface of Neisseria meningitidis and its accessibility in the presence of serogroup B capsular polysaccharide
|
McNeil, Lisa K.
|
|
2009
|
27 |
25-26 |
p. 3417-3421
5 p.
|
article
|
| 11 |
Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3–14 years during the annual health examination in private paediatric offices
|
Salleras, L.
|
|
2009
|
27 |
25-26 |
p. 3454-3458
5 p.
|
article
|
| 12 |
Editorial Board
|
|
|
2009
|
27 |
25-26 |
p. CO2-
1 p.
|
article
|
| 13 |
Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines
|
Yong, Michelle
|
|
2009
|
27 |
25-26 |
p. 3313-3318
6 p.
|
article
|
| 14 |
Flu vaccination with a virosomal vaccine does not affect clinical course and immunological parameters in scleroderma patients
|
Setti, Maurizio
|
|
2009
|
27 |
25-26 |
p. 3367-3372
6 p.
|
article
|
| 15 |
Gender effects on humoral immune responses to smallpox vaccine
|
Kennedy, Richard B.
|
|
2009
|
27 |
25-26 |
p. 3319-3323
5 p.
|
article
|
| 16 |
Genome-based approaches to develop vaccines against bacterial pathogens
|
Serruto, Davide
|
|
2009
|
27 |
25-26 |
p. 3245-3250
6 p.
|
article
|
| 17 |
Heterogeneous in vivo expression of clumping factor A and capsular polysaccharide by Staphylococcus aureus: Implications for vaccine design
|
Nanra, Jasdeep S.
|
|
2009
|
27 |
25-26 |
p. 3276-3280
5 p.
|
article
|
| 18 |
HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine
|
Ovsyannikova, Inna G.
|
|
2009
|
27 |
25-26 |
p. 3349-3358
10 p.
|
article
|
| 19 |
Homologous prime-boost strategy in neonate mice using Neisseria lactamica
|
Ito, André Y.
|
|
2009
|
27 |
25-26 |
p. 3422-3428
7 p.
|
article
|
| 20 |
Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection
|
Thomas, Linda D.
|
|
2009
|
27 |
25-26 |
p. 3324-3330
7 p.
|
article
|
| 21 |
Immune surveillance and immunotherapy: Lessons from carbohydrate mimotopes
|
Pashov, Anastas
|
|
2009
|
27 |
25-26 |
p. 3405-3415
11 p.
|
article
|
| 22 |
Immunization with the 7-valent conjugate pneumococcal vaccine: Impact evaluation, continuing surveillance and future perspectives
|
Bechini, Angela
|
|
2009
|
27 |
25-26 |
p. 3285-3290
6 p.
|
article
|
| 23 |
Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants
|
Shoji, Yoko
|
|
2009
|
27 |
25-26 |
p. 3467-3470
4 p.
|
article
|
| 24 |
Immunosuppressive mechanisms in cancer: Consequences for the development of therapeutic vaccines
|
Gross, Stefanie
|
|
2009
|
27 |
25-26 |
p. 3398-3400
3 p.
|
article
|
| 25 |
Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination
|
Ovsyannikova, Inna G.
|
|
2009
|
27 |
25-26 |
p. 3359-3366
8 p.
|
article
|
| 26 |
Influenza vaccination in patients with cirrhosis and in liver transplant recipients
|
Gaeta, Giovanni B.
|
|
2009
|
27 |
25-26 |
p. 3373-3375
3 p.
|
article
|
| 27 |
Is the vaccination coverage established enough to control pertussis, or it is a re-emerging disease?
|
Cardeñosa, Neus
|
|
2009
|
27 |
25-26 |
p. 3489-3491
3 p.
|
article
|
| 28 |
Lentiviral vectors for HIV disease prevention and treatment
|
Lemiale, Franck
|
|
2009
|
27 |
25-26 |
p. 3443-3449
7 p.
|
article
|
| 29 |
Mechanism of action of licensed vaccine adjuvants
|
Tritto, Elaine
|
|
2009
|
27 |
25-26 |
p. 3331-3334
4 p.
|
article
|
| 30 |
Mumps: A year of enhanced surveillance in Catalonia, Spain
|
Dominguez, Angela
|
|
2009
|
27 |
25-26 |
p. 3492-3495
4 p.
|
article
|
| 31 |
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy
|
Thapa, Prakash
|
|
2009
|
27 |
25-26 |
p. 3484-3488
5 p.
|
article
|
| 32 |
New perspectives for hepatitis B vaccines and immunization
|
Rapicetta, Maria
|
|
2009
|
27 |
25-26 |
p. 3271-3275
5 p.
|
article
|
| 33 |
Novel prophylactic and therapeutic vaccine against tuberculosis
|
Okada, Masaji
|
|
2009
|
27 |
25-26 |
p. 3267-3270
4 p.
|
article
|
| 34 |
Novel SIVmac DNA vaccines encoding Env, Pol and Gag consensus proteins elicit strong cellular immune responses in cynomolgus macaques
|
Yan, Jian
|
|
2009
|
27 |
25-26 |
p. 3260-3266
7 p.
|
article
|
| 35 |
On the relationship between meningococcal transmission dynamics and disease: Remarks on humoral immunity
|
Guzzetta, Giorgio
|
|
2009
|
27 |
25-26 |
p. 3429-3434
6 p.
|
article
|
| 36 |
Peptide therapy for anti-CD4 autoimmunity in HIV-1 infection: Toward the development of an autoimmune animal model
|
Abulafia-Lapid, R.
|
|
2009
|
27 |
25-26 |
p. 3475-3480
6 p.
|
article
|
| 37 |
Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up
|
Longo, Olimpia
|
|
2009
|
27 |
25-26 |
p. 3306-3312
7 p.
|
article
|
| 38 |
Plants as biofactories for the production of subunit vaccines against bio-security-related bacteria and viruses
|
Rigano, M. Manuela
|
|
2009
|
27 |
25-26 |
p. 3463-3466
4 p.
|
article
|
| 39 |
Preface
|
Kurstak, Edouard
|
|
2009
|
27 |
25-26 |
p. 3239-
1 p.
|
article
|
| 40 |
Prophylactic HPV vaccination for women over 18 years of age
|
Adams, M.
|
|
2009
|
27 |
25-26 |
p. 3391-3394
4 p.
|
article
|
| 41 |
Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses
|
Liniger, Matthias
|
|
2009
|
27 |
25-26 |
p. 3299-3305
7 p.
|
article
|
| 42 |
Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma
|
Cantarella, Giuseppina
|
|
2009
|
27 |
25-26 |
p. 3385-3390
6 p.
|
article
|
| 43 |
Safety experience with heptavalent pneumococcal CRM197-conjugate vaccine (Prevenar®) since vaccine introduction
|
Center, Kimberly J.
|
|
2009
|
27 |
25-26 |
p. 3281-3284
4 p.
|
article
|
| 44 |
Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: The Italian epidemiological scenario
|
Gasparini, R.
|
|
2009
|
27 |
25-26 |
p. 3435-3438
4 p.
|
article
|
| 45 |
SEVENTH WORLD CONGRESS ON VACCINES, IMMUNISATION AND IMMUNOTHERAPY
|
|
|
2009
|
27 |
25-26 |
p. 3499-
1 p.
|
article
|
| 46 |
Testing vaccines in pediatric research subjects
|
Jacobson, Robert M.
|
|
2009
|
27 |
25-26 |
p. 3291-3294
4 p.
|
article
|
| 47 |
The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination
|
Romanò, Luisa
|
|
2009
|
27 |
25-26 |
p. 3439-3442
4 p.
|
article
|
| 48 |
Trends affecting the future of vaccine development and delivery: The role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics
|
Poland, Gregory A.
|
|
2009
|
27 |
25-26 |
p. 3240-3244
5 p.
|
article
|
| 49 |
Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy
|
Durando, Paolo
|
|
2009
|
27 |
25-26 |
p. 3459-3462
4 p.
|
article
|
| 50 |
Vaccination of people at increased risk of influenza complications in Italy: How far have we gone?
|
Pariani, Elena
|
|
2009
|
27 |
25-26 |
p. 3342-3344
3 p.
|
article
|
| 51 |
Vaccine adverse event monitoring systems across the European Union countries: Time for unifying efforts
|
Zanoni, Giovanna
|
|
2009
|
27 |
25-26 |
p. 3376-3384
9 p.
|
article
|
| 52 |
Vaccines in a hurry
|
Søborg, Christian
|
|
2009
|
27 |
25-26 |
p. 3295-3298
4 p.
|
article
|
Journal description